ArticleClinical rheumatology2025

Comparison of the clinical efficacy and pharmacoeconomics of tofacitinib and adalimumab in Chinese patients with rheumatoid arthritis: An analysis based on propensity score matching.

Qin-Yao Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.